Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · September 20, 2023

Clinical Response to Low-Dose Omalizumab in Patients With Chronic Spontaneous Urticaria

Acta Dermato-Venereologica

 

Additional Info

Acta Dermato-Venereologica
Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients
Acta Derm Venereol 2023 Aug 30;103(xx)adv11627, MJ Kim, BR Kim, SH Kim, YS Chang, SW Youn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading